印度卫生部禁止非处方药销售GLP-1减肥药. Indian Health Ministry bans OTC sales of GLP-1 weight loss drugs.

印度政府已发布严格的指导方针,要求对用于治疗2型糖尿病和肥胖症的GLP-1药物进行医疗监督. The Indian government has issued strict guidelines requiring medical supervision for GLP-1 drugs used to treat type 2 diabetes and obesity. 由于人们担心在线平台和健康诊所的不受管制访问, 当局禁止非处方销售并加强检查以防止滥用. Authorities have banned over-the-counter sales and are intensifying inspections to prevent misuse after concerns arose over unregulated access through online platforms and wellness clinics.